The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 6 , Pages 1448-1454 , June 2007

Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas

  • Morihito Okada, MD, PhD

      Affiliations

    • Department of Thoracic Surgery, Hyogo Medical Center for Adults, Akashi City, Hyogo, Japan
    • Corresponding Author InformationAddress for reprints: Morihito Okada, MD, PhD, Department of Surgical Oncology, Hiroshima University, 1-2-3 Kasumi Minami-Ku, Hiroshima City 734-8551, Japan.
    • ,
  • Shunsuke Tauchi, MD

      Affiliations

    • Department of Thoracic Surgery, Hyogo Medical Center for Adults, Akashi City, Hyogo, Japan
    • ,
  • Koichiro Iwanaga, MD

      Affiliations

    • Department of Thoracic Surgery, Hyogo Medical Center for Adults, Akashi City, Hyogo, Japan
    • ,
  • Takeshi Mimura, MD

      Affiliations

    • Department of Thoracic Surgery, Hyogo Medical Center for Adults, Akashi City, Hyogo, Japan
    • ,
  • Yoshitaka Kitamura, MD

      Affiliations

    • Department of Thoracic Surgery, Hyogo Medical Center for Adults, Akashi City, Hyogo, Japan
    • ,
  • Hirokazu Watanabe, MD, PhD

      Affiliations

    • Department of Radiology, Hyogo Medical Center for Adults, Akashi City, Hyogo, Japan
    • ,
  • Shuji Adachi, MD, PhD

      Affiliations

    • Department of Radiology, Hyogo Medical Center for Adults, Akashi City, Hyogo, Japan
    • ,
  • Toshiko Sakuma, MD, PhD

      Affiliations

    • Department of Pathology, Hyogo Medical Center for Adults, Akashi City, Hyogo, Japan.
    • ,
  • Chiho Ohbayashi, MD, PhD

      Affiliations

    • Department of Pathology, Hyogo Medical Center for Adults, Akashi City, Hyogo, Japan.

Received 12 December 2006 ,Revised 2 February 2007 ,Accepted 19 February 2007.

References 

  1. Ginsberg RJ, Rubinstein LV Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60:615–622
  2. Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg. 2006;132:769–775
  3. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa M, et al. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg. 2005;129:87–93
  4. Okada M, Nishio W, Sakamoto T, Uchino K, Hanioka K, Ohbayashi C, et al. Correlation between computed tomographic findings, bronchioloalveolar carcinoma component, and biologic behavior of small-sized lung adenocarcinomas. J Thorac Cardiovasc Surg. 2004;127:857–861
  5. Okada M, Nishio W, Sakamoto T, Uchino K, Tsubota N. Discrepancy of computed tomographic image between lung and mediastinal windows as a prognostic implication in small lung adenocarcinoma. Ann Thorac Surg. 2003;76:1828–1832
  6. Nomori H, Watanage K, Ohtsuka T, Naruke T, Suemasu K, Kobayashi T, et al. Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1 N0 M0 lung adenocarcinoma. J Thorac Cardiovasc Surg. 2004;128:396–401
  7. Cerfolio RJ, Ojha B, Bryant AS, Bass CS, Bartalucci AA, Mountz JM. The role of FGD-PET scan in staging patients with non small cell carcinoma. Ann Thorac Surg. 2003;76:861–866
  8. Cerfolio RJ, Bryant AS, Ojha B. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study. J Thorac Cardiovasc Surg. 2006;131:1229–1235
  9. McCain TW, Dunagan DP, Chin R, Oaks T, Harkness BA, Haponik EF. The usefulness of positron emission tomography in evaluating patients for pulmonary malignancies. Chest. 2000;118:1610–1615
  10. Pieterman RM, van Putten JW, Meuzelaar JJ, Mooyaart EL, Vaalburg W, Koeter GH, et al. Preoperative staging of non–small cell lung cancer with positron emission tomography. N Engl J Med. 2000;343:254–261
  11. Cerfolio RJ, Bryant AS, Ohja B, Bartolucci AA. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg. 2005;130:151–159
  12. Dhital K, Saunders CAB, Seed PT, O’Doherty MJ, Dussek J. [18F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer. Eur J Cardiothorac Surg. 2000;18:425–428
  13. Vansteenkiste J, Fischer BM, Dooms C, Mortensen J. Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review. Lancet Oncol. 2004;5:531–540
  14. Ahuja V, Coleman RE, Herndon J, Patz EF. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma. Cancer. 1998;83:918–924
  15. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. 1997;111:1710–1717
  16. Lee JR, Madsen MT, Bushnel D, Menda Y. A threshold method to improve standardized uptake value reproducibility. Nucl Med Commun. 2000;21:685–690
  17. Takamochi K, Nagai K, Yoshida J, Suzuki K, Ohde Y, Nishimura M, et al. Pathologic N0 status in pulmonary adenocarcinoma is predictable by combining serum carcinoembryonic antigen level and computed tomographic findings. J Thorac Cardiovasc Surg. 2001;122:325–330
  18. Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S, et al. Small adenocarcinoma of the lung (Histologic characteristics and prognosis). Cancer. 1995;75:2844–2852
  19. Goldstein NS, Mani A, Chmielewski G, Welsh R, Pursel S. Prognostic factors in T1 N0 M0 adenocarcinomas and bronchioloalveolar carcinomas of the lung. Am J Clin Pathol. 1999;112:391–402
  20. Yap CS, Schiepers C, Fishbein MC, Phelps ME, Czernin J. FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma?. Eur J Nucl Med Mol Imaging. 2002;29:1166–1173
  21. Heyneman LE, Patz EF. PET imaging in patients with bronchioloalveolar cell carcinoma. Lung Cancer. 2002;38:261–266
  22. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, et al. Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease. Ann Thorac Surg. 2004;78:216–221
  23. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, et al. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma. Ann Thorac Surg. 2004;78:1004–1009

PII: S0022-5223(07)00459-X

doi: 10.1016/j.jtcvs.2007.02.023

The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 6 , Pages 1448-1454 , June 2007

Article Tools

* Image Usage & Resolution